Cortical Haemodynamic Response Measured by Functional Near Infrared Spectroscopy During a Verbal Fluency Task in Patients with Major Depression and Borderline Personality Disorder

Overview

Journal EBioMedicine

Specialty Biomedical Engineering

Date 2019 Dec 27

PMID 31877417

Citations 70

Authors

Syeda F Husain

Tong-Boon Tang

Rongjun Yu

Wilson W Tam

Bach Tran

Travis T Quek

Shi-Hui Hwang

Cheryl W Chang

Cyrus S Ho

Roger C Ho

Affiliations

Soon will be listed here.

Abstract

Background: Functional near infrared spectroscopy (fNIRS) provides a direct and quantitative assessment of cortical haemodynamic function during a cognitive task. This functional neuroimaging modality may be used to elucidate the pathophysiology of psychiatric disorders, and identify neurophysiological differences between co-occurring psychiatric disorders. However, fNIRS research on borderline personality disorder (BPD) has been limited. Hence, this study aimed to compare cerebral haemodynamic function in healthy controls (HC), patients with major depressive disorder (MDD) and patients with BPD.

Methods: fNIRS signals during a verbal fluency task designed for clinical assessment was recorded for all participants. Demographics, clinical history and symptom severity were also noted.

Findings: Compared to HCs (n = 31), both patient groups (MDD, n = 31; BPD, n = 31) displayed diminished haemodynamic response in the frontal, temporal and parietal cortices. Moreover, haemodynamic response in the right frontal cortex is markedly lower in patients with MDD compared to patients with BPD.

Interpretation: Normal cortical function in patients with BPD is disrupted, but not as extensively as in patients with MDD. These results provide further neurophysiological evidence for the distinction of patients with MDD from patients with BPD.

Citing Articles

Multimodal Fusion of EEG and Audio Spectrogram for Major Depressive Disorder Recognition Using Modified DenseNet121.

Yousufi M, Damasevicius R, Maskeliunas R Brain Sci. 2024; 14(10).

PMID: 39452032 PMC: 11505707. DOI: 10.3390/brainsci14101018.

Distinction of mental health between salesman and R&D in high-tech enterprise: a fNIRS study.

Liu Q, Cui H, Yuan P, Liu J, Jin Y, Xia L Sci Rep. 2024; 14(1):22371.

PMID: 39333762 PMC: 11437019. DOI: 10.1038/s41598-024-74216-8.

Biomarker-Guided Tailored Therapy in Major Depression.

Perna G, Spiti A, Torti T, Dacco S, Caldirola D Adv Exp Med Biol. 2024; 1456:379-400.

PMID: 39261439 DOI: 10.1007/978-981-97-4402-2_19.

Large Individual Differences in Functional Connectivity in the Context of Major Depression and Antidepressant Pharmacotherapy.

van der Wijk G, Zamyadi M, Bray S, Hassel S, Arnott S, Frey B eNeuro. 2024; 11(6).

PMID: 38830756 PMC: 11163402. DOI: 10.1523/ENEURO.0286-23.2024.

Parkinson's disease patients show delayed hemodynamic changes in primary motor cortex in fine motor tasks and decreased resting-state interhemispheric functional connectivity: a functional near-infrared spectroscopy study.

Guevara E, Rivas-Ruvalcaba F, Kolosovas-Machuca E, Ramirez-Elias M, de Leon Zapata R, Ramirez-Garcialuna J Neurophotonics. 2024; 11(2):025004.

PMID: 38812966 PMC: 11135928. DOI: 10.1117/1.NPh.11.2.025004.

References

Thomas N, Gurvich C, Hudaib A, Gavrilidis E, Kulkarni J . Systematic review and meta-analysis of basal cortisol levels in Borderline Personality Disorder compared to non-psychiatric controls. Psychoneuroendocrinology. 2018; 102:149-157. DOI: 10.1016/j.psyneuen.2018.12.009. View

Zimmerman M, Martinez J, Young D, Chelminski I, Dalrymple K . Severity classification on the Hamilton Depression Rating Scale. J Affect Disord. 2013; 150(2):384-8. DOI: 10.1016/j.jad.2013.04.028. View

Brune M . On the role of oxytocin in borderline personality disorder. Br J Clin Psychol. 2015; 55(3):287-304. DOI: 10.1111/bjc.12100. View

Gunderson J . Clinical practice. Borderline personality disorder. N Engl J Med. 2011; 364(21):2037-42. DOI: 10.1056/NEJMcp1007358. View

Gsell W, De Sadeleer C, Marchalant Y, MacKenzie E, Schumann P, Dauphin F . The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: experimental and pathophysiological considerations. J Chem Neuroanat. 2001; 20(3-4):215-24. DOI: 10.1016/s0891-0618(00)00095-8. View

Bayes A, Parker G . Borderline personality disorder in men: A literature review and illustrative case vignettes. Psychiatry Res. 2017; 257:197-202. DOI: 10.1016/j.psychres.2017.07.047. View

Ruocco A, Medaglia J, Ayaz H, Chute D . Abnormal prefrontal cortical response during affective processing in borderline personality disorder. Psychiatry Res. 2010; 182(2):117-22. DOI: 10.1016/j.pscychresns.2010.01.011. View

Depping M, Wolf N, Vasic N, Sambataro F, Thomann P, Wolf R . Specificity of abnormal brain volume in major depressive disorder: a comparison with borderline personality disorder. J Affect Disord. 2015; 174:650-7. DOI: 10.1016/j.jad.2014.11.059. View

Silk K . The quality of depression in borderline personality disorder and the diagnostic process. J Pers Disord. 2010; 24(1):25-37. DOI: 10.1521/pedi.2010.24.1.25. View

10.

Hayasaka Y, Purgato M, Magni L, Ogawa Y, Takeshima N, Cipriani A . Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. J Affect Disord. 2015; 180:179-84. DOI: 10.1016/j.jad.2015.03.021. View

11.

Crockett D, Bilsker D, Hurwitz T, Kozak J . Clinical utility of three measures of frontal lobe dysfunction in neuropsychiatric samples. Int J Neurosci. 1986; 30(4):241-8. DOI: 10.3109/00207458608985674. View

12.

Riffer F, Farkas M, Streibl L, Kaiser E, Sprung M . Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines. Int J Psychiatry Clin Pract. 2019; 23(3):178-188. DOI: 10.1080/13651501.2019.1576904. View

13.

Rausch J, Gabel A, Nagy K, Kleindienst N, Herpertz S, Bertsch K . Increased testosterone levels and cortisol awakening responses in patients with borderline personality disorder: gender and trait aggressiveness matter. Psychoneuroendocrinology. 2015; 55:116-27. DOI: 10.1016/j.psyneuen.2015.02.002. View

14.

Mitchell A, Dickens G, Picchioni M . Facial emotion processing in borderline personality disorder: a systematic review and meta-analysis. Neuropsychol Rev. 2014; 24(2):166-84. DOI: 10.1007/s11065-014-9254-9. View

15.

Ruocco A, Medaglia J, Tinker J, Ayaz H, Forman E, Newman C . Medial prefrontal cortex hyperactivation during social exclusion in borderline personality disorder. Psychiatry Res. 2010; 181(3):233-6. DOI: 10.1016/j.pscychresns.2009.12.001. View

16.

Latas M, Milovanovic S . Personality disorders and anxiety disorders: what is the relationship?. Curr Opin Psychiatry. 2013; 27(1):57-61. DOI: 10.1097/YCO.0000000000000025. View

17.

Gunderson J, Morey L, Stout R, Skodol A, Shea M, McGlashan T . Major depressive disorder and borderline personality disorder revisited: longitudinal interactions. J Clin Psychiatry. 2004; 65(8):1049-56. DOI: 10.4088/jcp.v65n0804. View

18.

Kolla N, Chiuccariello L, Wilson A, Houle S, Links P, Bagby R . Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition. Biol Psychiatry. 2015; 79(2):117-26. PMC: 4942262. DOI: 10.1016/j.biopsych.2014.11.024. View

19.

Ruocco A, Carcone D . A Neurobiological Model of Borderline Personality Disorder: Systematic and Integrative Review. Harv Rev Psychiatry. 2016; 24(5):311-29. DOI: 10.1097/HRP.0000000000000123. View

20.

Stoffers J, Lieb K . Pharmacotherapy for borderline personality disorder--current evidence and recent trends. Curr Psychiatry Rep. 2014; 17(1):534. DOI: 10.1007/s11920-014-0534-0. View